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Supplementary Methods  28 
Preparation of soluble rat brain extract and purification of tubulin. Brains from 15- 29 
to 30-day-old Wistar rats were homogenized in 1 vol MEM buffer (100 mM MES buffer 30 
adjusted with NaOH to pH 6.7, containing 1 mM EGTA, 1 mM MgCl2, and a mixture of 31 
protease inhibitors; Sigma). The homogenate was centrifuged at 100,000 x g for 1 h at 32 
2-4°C,and supernatant solution was collected and used immediately. For purification of 33 
tubulin, 1x cycled microtubule protein was chromatographed on a Mono-Q column (GE 34 
Healthcare; Pittsburgh, PA, USA) as described previously1. 35 
 36 
Generation of a specific Phe-tubulin antibody. The immunization protocol was 37 
similar to that we used previously for production of antisera specific to 3-nitro-Tyr-tubulin 38 
and to azatyrosine-tubulin 2, 3. In brief, Gly-Glu-Glu-Phe peptide (C-terminus of α-tubulin 39 
with Tyr replaced by Phe) was bound through its amino group to KLH using 40 
glutaraldehyde as a crosslinker. The resulting protein (500 µg) was mixed with complete 41 
Freund’s adjuvant (1:1, v/v) and used for the primary injection. Subsequent booster 42 
immunizations were performed every 15 days, using 500 µg of the same protein 43 
preparation emulsified in incomplete adjuvant. Blood was collected 15 days after each 44 
injection, and sera were tested for affinity and specificity. 45 
 46 
Specificity of polyclonal antibody. Freshly prepared soluble rat brain extract was 47 
treated with 10 µg/mL pancreatic carboxypeptidase A (CPA) for 30 min at 37 ºC and 48 
then passed through a Sephadex G-25-80 column equilibrated with MEM buffer to 49 
eliminate free amino acids. CPA was inactivated by 50 µg/mL of CPA inhibitor (CPI). 50 
Aliquots of the resulting preparation were incubated 30 min at 37ºC with 1 mM Tyr or 1 51 
mM Phe under incorporating conditions (per mL incubating medium: 0.9 mL soluble 52 
brain extract, 2.5 µmol ATP, 12.5 µmol MgCl2, 30 µmol KCl, 100 µmol MES buffer, pH 53 
6.7). When incubation was completed, Laemmli sample buffer was added, and samples 54 
were immunoblotted and stained with antibodies directed to Total-, Tyr-, or Phe-tubulin 55 
(1:1000). 56 
 57 
Quantification of Phe-tubulin. Absolute amounts of Phe-tubulin were measured using 58 
cultured HeLa cells, which contain only Tyr-tubulin and no Glu-tubulin.Total-tubulin 59 
amount was determined by comparison with pure tubulin standard. These data provided 60 
a useful Tyr-tubulin standard and were used to obtain a standard curve of optical 61 
density as a function of ng Tyr-tubulin. A standard curve for Glu-tubulin was obtained by 62 
treating HeLa cell tubulin with CPA, which transformed all Tyr-tubulin to Glu-tubulin. 63 
 64 
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Supplementary Figure 1: Specificity of anti-Phe-tubulin antibody. Soluble rat brain 69 
extract (SN, stained with Coomassie Blue) was treated with CPA and then with the CPA 70 
inhibitor CPI. Two separate aliquots were incubated under conditions for incorporation 71 
of Tyr (lanes 1) or Phe (lanes 2) into the C-terminus of α-tubulin, and then subjected to 72 
Western blotting and immunostaining with antibodies directed to Total-tub, Tyr-Tub, or 73 
Phe-Tub. For the two right-hand blots, anti-Phe-tubulin antibody was incubated 1 h at 74 
25 ºC in the presence of 500 µM Tyr or 500 µM Phe. 75 
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Supplementary Figure 2: Standard curves for quantification of Total-, Tyr- and 80 
Glu-tub: (a) Purified rat brain tubulin was subjected to SDS-PAGE (10% acrylamide) 81 
and stained with Coomassie Brilliant Blue (left). HeLa cells were harvested, pelleted by 82 
centrifugation, resuspended in MEM buffer, and sonicated. After centrifugation at 83 
100,000 x g for 30 min at 2-4ºC, aliquots of the supernatant fraction were incubated in 84 
the absence or presence of 10 μg/mL CPA for 15 min, and inactivated by dilution with 85 
1x Laemmli sample buffer and heating at 90ºC for 5 min. Samples were subjected to 86 
Western blotting and stained with antibodies to Tyr-, Glu-, and Δ2-tubulin. (b) The 87 
indicated amounts of purified rat brain tubulin were subjected to Western blotting and 88 
stained with anti-Total-tubulin antibody. (c) The indicated amounts of HeLa cell tubulin 89 
(not treated with CPA), representing equivalent amounts of the Tyr-tubulin isospecies, 90 
were subjected to Western blotting and stained with anti-Tyr-tubulin antibody. (d) The 91 
indicated amounts of HeLa cell tubulin (treated with CPA), representing equivalent 92 
amounts of the Glu-tubulin isospecies, were subjected to Western blotting and stained 93 
with anti-Glu-tubulin antibody. Optical densities of all bands were measured. Only 94 
optical density values within the linear range are shown. 95 
96 
Supplementary Table 1. Quantification of Phe-tubulin in CAD cell extracts. 97 
By using curves from Supplementary Fig. 2,  we determined by Western blotting the 98 
amounts of Tyr-, Glu- and Total-tubulin in CAD cells previously incubated for 48 h in the 99 
absence or presence of 4 mM Phe.  The amount of Phe-tubulin was estimated from the 100 
difference between Total-tubulin minus the sum of Tyr- plus Glu-tubulin. Results are 101 
expressed in ng and the percentage of Phe-tubulin is shown in parentheses. Results 102 
are from 3 independent experiments.  103 
 104 
                               Total-tub       Tyr-tub      Glu-tub                  Phe-tub      105 
                                                                                         __________________       106 
                                   ng                ng              ng                 ng              (%)   107 
                                  (A)                (B)             (C)            A-(B+C) 108 
_______________________________________________________________   109 
 110 
    No Phe               104±7           79±5           20±3              5±1          (4%±1) 111 
+ 4 mM Phe, 112 
    t = 48 h               106±8           44±4           13±2            49±4          (46%±4) 113 
 114 
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